OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation (2013) Vol. 19, Iss. 7, pp. 1006-1012
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access

Antithymocyte Globulin in Allogeneic Hematopoietic Cell Transplantation: Benefits and Limitations
Taiga Nishihori, Zaid Al‐Kadhimi, Mehdi Hamadani, et al.
Immunotherapy (2016) Vol. 8, Iss. 4, pp. 435-447
Closed Access | Times Cited: 31

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond
Naveen Pemmaraju
Current Hematologic Malignancy Reports (2017) Vol. 12, Iss. 6, pp. 510-512
Closed Access | Times Cited: 30

Blastic Plasmacytoid Dendritic Cell Neoplasm
Éric Deconinck, Tony Petrella, Francine Garnache Ottou
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 491-500
Open Access | Times Cited: 21

Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm
Tongyuan Xue, Lihua E. Budde
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 575-587
Closed Access | Times Cited: 21

Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experience
Thomas Heinicke, Heiko Hütten, Thomas Kalinski, et al.
Annals of Hematology (2014) Vol. 94, Iss. 2, pp. 283-287
Closed Access | Times Cited: 22

New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19

Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
Hae Su Kim, Hee‐Jin Kim, Sun‐Hee Kim, et al.
The Korean Journal of Internal Medicine (2017) Vol. 32, Iss. 5, pp. 890-899
Open Access | Times Cited: 20

Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature
Chan Liao, Nan-Xia Hu, Hua Song, et al.
International Journal of Hematology (2021) Vol. 113, Iss. 5, pp. 751-759
Closed Access | Times Cited: 16

Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury
Jessica El-Asmar, Rebecca Gonzalez, Ryan Bookout, et al.
Hematology/Oncology and Stem Cell Therapy (2015) Vol. 9, Iss. 4, pp. 157-161
Open Access | Times Cited: 17

A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm
Umberto Falcone, Hassan Sibai, Uday Deotare
Critical Reviews in Oncology/Hematology (2016) Vol. 107, pp. 156-162
Closed Access | Times Cited: 17

Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al.
Current Hematologic Malignancy Reports (2016) Vol. 11, Iss. 6, pp. 462-467
Closed Access | Times Cited: 16

Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Mansour Alfayez, Marina Konopleva, Naveen Pemmaraju
Expert Opinion on Biological Therapy (2019) Vol. 20, Iss. 2, pp. 115-123
Closed Access | Times Cited: 15

Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm
Mohamed A. Kharfan‐Dabaja, Mohamad Cherry
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 621-629
Closed Access | Times Cited: 14

Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database
Xiao-Jing Lin, Li Wang, Qian Hu, et al.
European Journal Of Haematology (2023) Vol. 110, Iss. 6, pp. 743-753
Closed Access | Times Cited: 5

Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.
Current Hematologic Malignancy Reports (2017) Vol. 12, Iss. 6, pp. 592-597
Closed Access | Times Cited: 14

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 581-587
Closed Access | Times Cited: 14

Expression of CD31/PECAM-1 (Platelet Endothelial Cell Adhesion Molecule 1) by Blastic Plasmacytoid Dendritic Cell Neoplasms
Katrin A. Salva, Anna Haemel, Laura B. Pincus, et al.
JAMA Dermatology (2013) Vol. 150, Iss. 1, pp. 73-73
Open Access | Times Cited: 13

Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease
Uday Deotare, Dennis Dong Hwan Kim, Fotios V. Michelis, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2015) Vol. 57, Iss. 8, pp. 1942-1944
Closed Access | Times Cited: 13

Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13

A case series of blastic plasmacytoid dendritic cell neoplasia
Valentina Giudice
Translational Medicine UniSa (2020) Vol. 23, Iss. 4
Open Access | Times Cited: 12

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
Mohamed A. Kharfan‐Dabaja, Rocío Parody, Janelle Perkins, et al.
Bone Marrow Transplantation (2016) Vol. 52, Iss. 3, pp. 438-444
Open Access | Times Cited: 10

Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?
Mathieu Leclerc, Régis Peffault de Latour, Mauricette Michallet, et al.
Blood (2016) Vol. 129, Iss. 9, pp. 1227-1230
Open Access | Times Cited: 10

Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion
Cyndi Myrelle da Silva Barros Romão, Cláudio José dos Santos Júnior, Luiz Arthur Calheiros Leite, et al.
American Journal of Case Reports (2017) Vol. 18, pp. 692-695
Open Access | Times Cited: 10

Transplantation in Rare Lymphoproliferative and Histiocytic Disorders
Alexis Cruz-Chacón, John Mathews, Ernesto Ayala
Cancer Control (2014) Vol. 21, Iss. 4, pp. 335-342
Open Access | Times Cited: 8

Scroll to top